-
-
Call more information
660-596-2224 -
AUTHORS: Farag, Ehab MD, FCRA, FASA et al Anesthesia & Analgesia: June 2021 – Volume 132 – Issue 6 – p 1666-1676 BACKGROUND: Catheter-based endovascular neurointerventions require deep neuromuscular blocks during the procedure and rapid subsequent recovery of strength to facilitate neurological evaluation. We tested the primary hypothesis that sugammadex reverses deep neuromuscular blocks faster than […]
Read MoreAUTHORS: Gregory, Anne MD, MSc, FRCPC et al Anesthesia & Analgesia: June 2021 – Volume 132 – Issue 6 – p 1654-1665 BACKGROUND: Intraoperative hypotension (IOH) occurs frequently during surgery and may be associated with organ ischemia; however, few multicenter studies report data regarding its associations with adverse postoperative outcomes across varying hemodynamic thresholds. Additionally, no […]
Read MoreAUTHORS: Flamée, Panagiotis MD et al Anesthesia & Analgesia: June 2021 – Volume 132 – Issue 6 – p 1645-1653 BACKGROUND: Propofol administration in patients with Brugada syndrome (BrS) is still a matter of debate. Despite lacking evidence for its feared arrhythmogenicity, up to date, expert cardiologists recommend avoiding propofol. The main aim of this […]
Read MoreAUTHORS: Boswell, Michael R. MD et al Anesthesia & Analgesia: June 2021 – Volume 132 – Issue 6 – p 1635-1644 BACKGROUND: Patients with existing coronary artery stents are at an increased risk for major adverse cardiac events (MACEs) when undergoing noncardiac surgery (NCS). Although the use of antifibrinolytic (AF) therapy in NCS has significantly increased […]
Read MoreAUTHORS: Jin, Zhaosheng MBBS et al Anesthesia & Analgesia: June 2021 – Volume 132 – Issue 6 – p 1626-1634 BACKGROUND: Pain is one of the most common adverse events after surgery. Regional anesthesia techniques are effective for pain control but have limited duration of action. Liposomal bupivacaine is a long-acting formulation of bupivacaine. We conduct […]
Read More